AI in Commercial Space & Aviation

What if the next breakthrough in AI-driven biotech isn’t about editing DNA — but about rewriting its instructions without touching the code? Today’s Nature paper on CRMA-1001, a single-injection epigenetic therapy that banishes hepatitis B by tagging viral DNA, reveals a new frontier: AI can now simulate and optimize non-destructive gene silencing at scale. This isn’t just about curing viruses — it’s about building AI systems that learn to manage biological persistence, not just disrupt it. The implications for long-duration space missions, where latent viruses reactivate under stress, are profound. Could AI predict which epigenetic tags will remain stable across decades of cellular division? The answer may lie in models trained on chromatin dynamics. This is the future of AI in aerospace medicine — not gene cutting, but precision epigenetic orchestration. Source: https://www.nature.com/articles/d41586-026-02981-9?error=cookies_not_supported&code=938a7dd9-0f53-454f-9f70-49f616dc2783 View and join any or all of our communities — AI, quantum, and real estate: https://alex-companies.com/reports/linkedin-groups If there's an AI, quantum, or real estate community you'd like to see us convene, tell us — this portfolio grows by request.